Joanne Wan, Ph.D., DABT, Principal Scientific Consultant, Toxicology
Dr. Joanne Wan joined Intertek in 2007 and has assisted clients with their
nonclinical toxicology development programs for products such as:
• Medical devices,
• Dermal drugs,
• Oncology drugs,
• Botanicals,
• Cannabinoids; and
• Psychedelic alkaloids
The breadth of experience includes the strategic design and outsourcing of nonclinical toxicology and safety pharmacology programs, reviewing study protocols, on- and off-site study monitoring of toxicology studies, reviewing study reports, and preparing and authoring regulatory submission documents.
Dr. Wan has extensive experience working closely with the Regulatory Affairs team at Intertek to complete and co-ordinate regulatory submissions for her clients and to facilitate interactions with Regulatory Agencies. Dr. Wan has provided scientific writing services for documents such as literature-based safety and efficacy submissions, Investigator’s Brochures, and clients in-house scientific study reports.
In addition to her work with the Pharmaceuticals & Healthcare group, Dr. Wan also works with the Customer Assurance group to perform toxicology risk assessments (TRAs) of consumer products, cosmetics, art materials, and toys that are marketed in Canada and the United States. She also serves as an internal resource on general toxicology, dermal toxicology, and reproductive and developmental toxicity issues.
Dr. Wan is an active member of the Society of Toxicology of Canada; serving as a member of the Annual meeting Program Committee (2018 to 2020) and on the Awards Committee (present). She is also a Full member of the SOT and is a Board-Certified toxicologist.
